Closing Bell: Arch Biopartners Inc down on Tuesday (ARCH)

In today's trading, Arch Biopartners Inc shares closed at $1.47 after opening the day at $1.56. prices ranged from $1.47 to $1.56.

Shares dipped -2.00% from the previous day's close of $1.50.

During the day across North America, the TSX Composite closed -0.26% at 22813.75, the S&P 500 closed 1.08% at 5564.41, the Dow Jones Industrial Average closed 0.32% at 40415.44 and the Nasdaq Composite closed 1.58% at 18007.57.

Arch Biopartners Inc has listed on the Toronto Venture Exchange (TSX-V) under the ticker ARCH.

Trading volume was 13,400 on 37 total trades, with an average volume of 21,871 over the last 5 days.

The TSX-V market on the whole today saw 3,093 price advancers against 2,137 declines and 96 unchanged.

During the prior 52 weeks, ARCH.VN has traded as high as $2.56 (March 18,2024) and low as $0.97 (November 03,2023). Moreover, the shares have shrunken -30.66% in the last year, while they have dipped -0.68% this year.

It announced a 0.05 dividend on January 01/70, with an December 05/89 ex-date and January 01/70 pay day.

Following today's trading, Arch Biopartners Inc has a market capitalization of $95.78 million on a float of 63,851 shares outstanding. Its annual EPS is $-0.03.

Arch Biopartners Inc is a TSX Biotechnology company headquartered in Toronto, CAN.

Currently, Arch Biopartners Inc's consensus rating is "Strong Sell" based on 0 analysts according to Zacks. Currently, there are for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..